Men within the age group of 31-45 years are at greater risks
SRL Diagnostics conducted a three year long data mining survey (2012 – 2014) which revealed increasing numbers of urban men are detected with thyroid disorders in the recent times. The study reveals that thyroid disorders, which are most commonly associated with women, are affecting men as well with serious consequences leading to heart problems, mental health issues, Infertility etc.
Of the 14, 24,008 screened for the study by SRL, 22.68 per cent, of the total samples were found with abnormal TSH levels. The younger population within the age group of 31-45 years was at higher risk of thyroid dysfunction (30.33 per cent of the samples) than the older population within the age group of 46-60 years (25.81 per cent of the samples). The analysis showed the highest prevalence of the disease among men in the Eastern zone of the country.
East zone had highest percentage of abnormality with 25. 2 per cent while Northern and Western zone had 23.9 per cent and 21.1 per cent respectively. Among the four zones, Southern India showed the lowest percentage of abnormality with 19.4 per cent.
Dr BR Das, President – Research and Innovation, Mentor – Molecular Pathology and Clinical Research Service of SRL Diagnostics says, “There is a significant need for reaching out and making people aware of the causes, symptoms, treatment and importance of testing for thyroid problems. SRL Diagnostic’s in-house data analysis on thyroid tests assesses the nationwide abnormalities in test results in men residing in various cities that represent diverse geographic origin, occupation, socio-economic status and food habits.”
A recent survey conducted by Indian Thyroid Society depicts awareness for the disease ranked ninth as compared to other common ailments such as asthma, cholesterol problem, depression, diabetes, insomnia and heart problem. The prevalence of hypothyroidism in the developed world is estimated to be about four or five per cent. According to the survey, the disease is more prevalent between the age group of 46-54 years.
The study findings call for an emphasis on active screening of endocrine function among patients at greater risk along with regular monitoring of thyroid status and dose adjustments to provide effective therapy in patients with established diagnosis.